Risk Factors of Blood Culture Positivity and Mortality in Bloodstream Infections: A Population‐Based Study of Patients With B‐Cell Malignancies
European Journal of Haematology · 2026
DOI: 10.1111/ejh.70246 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Haematology, 2026. Verfasst von Mathias Holmsgaard Eskesen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark. Hauptthemen laut MEDLINE: Blood Culture, Sepsis, Lymphoma, B-Cell, Bacteremia. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sygeforsikringen "danmark", Danish Data Science Academy.
Abstract (Originalsprache)
Background
Bloodstream infections remain a major cause of mortality among cancer patients. Pathogen surveillance and risk stratification tools are key to improved management. This study describes trends in causative pathogens and explores risk factors for positive blood cultures (PBCs) and post‐infection mortality in cancer patients.
Methods
We performed a cohort study of patients diagnosed with a B‐cell malignancy in the North Denmark Region between 2013 and 2022, linking cancer registry data to health records. Causative pathogens were described. LASSO regression was used to select variables associated with PBCs and post‐infection mortality. Odds ratios were estimated by univariate analyses.
Results
Among 1592 patients with B‐cell malignancies, 341 patients (21.4%) had at least one PBC, yielding 484 PBCs. We observed a shift from Gram‐positive to Gram‐negative dominance, driven by an increased frequency of the most common pathogen Escherichia coli (24.8%). Patients with neutropenia, elevated CRP, sepsis, hypotension, or kidney failure had a higher risk of a PBC. Advanced age, kidney failure, and sepsis were all associated with 30‐ and 90‐day post‐infection mortality.
Conclusion
Routinely available parameters obtained at time of admission were associated with blood culture positivity and mortality. Our findings support the rationale for developing predictive models to individualise infection management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark.
- Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
- Department of Materials and Production, Aalborg University, Aalborg, Denmark.
- Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
- Department of Haematology, Aarhus University Hospital, Aarhus, Denmark.
ORCID-Profile: Mathias Holmsgaard Eskesen, Alexander Djupnes Fuglkjær, Tarec Christoffer El-Galaly, Paw Jensen, Izabela Ewa Nielsen, Laurids Østergaard Poulsen, Mikkel Runason Simonsen, Kirstine Kobberøe Søgaard
Förderung
- Sygeforsikringen "danmark"
- Danish Data Science Academy
Zitieren
APA
Eskesen, M. H., Fuglkjær, A. D., El-Galaly, T. C., Jensen, P., Nielsen, I. E., Poulsen, L. Ø., Simonsen, M. R., & Søgaard, K. K. (2026). Risk Factors of Blood Culture Positivity and Mortality in Bloodstream Infections: A Population‐Based Study of Patients With B‐Cell Malignancies. European Journal of Haematology. https://doi.org/10.1111/ejh.70246
Vancouver
Eskesen MH, Fuglkjær AD, El-Galaly TC, Jensen P, Nielsen IE, Poulsen LØ, et al. Risk Factors of Blood Culture Positivity and Mortality in Bloodstream Infections: A Population‐Based Study of Patients With B‐Cell Malignancies. European Journal of Haematology. 2026. doi:10.1111/ejh.70246
BibTeX
@article{Eskesen2026,
author = {Eskesen, Mathias Holmsgaard and Fuglkjær, Alexander Djupnes and El-Galaly, Tarec Christoffer and Jensen, Paw and Nielsen, Izabela Ewa and Poulsen, Laurids Østergaard and Simonsen, Mikkel Runason and Søgaard, Kirstine Kobberøe},
title = {Risk Factors of Blood Culture Positivity and Mortality in Bloodstream Infections: A Population‐Based Study of Patients With B‐Cell Malignancies},
journal = {European Journal of Haematology},
year = {2026},
doi = {10.1111/ejh.70246}
}
EUVIMED